ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Calithera Biosciences Inc

Calithera Biosciences Inc (CALA)

0.20
0.00
( 0.00% )
Updated: 20:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.20
Bid
0.16
Ask
0.35
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.20
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
4,872,497
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-4.37
Revenue
-
Net Profit
-21.29M

About Calithera Biosciences Inc

Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumo... Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm functions through the region of the US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Calithera Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CALA. The last closing price for Calithera Biosciences was $0.20. Over the last year, Calithera Biosciences shares have traded in a share price range of $ 0.00 to $ 0.00.

Calithera Biosciences currently has 4,872,497 shares outstanding. The market capitalization of Calithera Biosciences is $974,499.40 . Calithera Biosciences has a price to earnings ratio (PE ratio) of 0.00.

CALA Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
156-1.86-90.29126213592.065.10.13912407490.68692706CS
260-4-95.23809523814.28.180.1399837362.16956715CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
POAIPredictive Oncology Inc
$ 1.95
(82.24%)
139.69M
PBMPsyence Biomedical Ltd
$ 0.6596
(68.52%)
67.11M
SLRXSalarius Pharmaceuticals Inc
$ 3.4299
(60.28%)
18.66M
VKTXViking Therapeutics Inc
$ 66.835
(32.58%)
10.07M
GSHDGoosehead Insurance Inc
$ 86.885
(32.25%)
615.2k
TWOU2U Inc
$ 1.545
(-62.50%)
3.43M
CTNTCheetah Net Supply Chain Service Inc
$ 0.2867
(-40.52%)
4.97M
KDLYKindly MD Inc
$ 1.92
(-40.37%)
563.97k
EZFLEzFill Holdings Inc
$ 4.0383
(-35.13%)
106.87k
SLGLSol Gel Technologies Ltd
$ 0.4494
(-32.93%)
13M
NVDANVIDIA Corporation
$ 114.49
(0.21%)
249.64M
POAIPredictive Oncology Inc
$ 1.95
(82.24%)
139.69M
SLNASelina Hospitality PLC
$ 0.0397
(-13.13%)
137.38M
SQQQProShares UltraPro Short QQQ
$ 9.0599
(-0.00%)
134.54M
PBMPsyence Biomedical Ltd
$ 0.6596
(68.52%)
67.11M

CALA Discussion

View Posts
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 1 year ago
maybe soon will see something
πŸ‘οΈ0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 1 year ago
maybe soon will see something
πŸ‘οΈ0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 1 year ago
looking close
πŸ‘οΈ0
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 1 year ago
cala soon something
πŸ‘οΈ0
Renee Renee 1 year ago
CALA delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
πŸ‘οΈ0
kzivann kzivann 1 year ago
CALA dissolving. https://quantisnow.com/insight/3950020
πŸ‘οΈ0
Mr. Zen Mr. Zen 2 years ago
Calithera continued to advance multiple vacuolar protein sorting-associated protein 4A (VPS4A) and VPS4B inhibitors through lead optimization and plans to share updates on this program by the end of 2022.
πŸ‘οΈ0
Nealio Nealio 2 years ago
CALA - continues upward. 100% gain in last month, very good swing play. Drug data was good...float is very low at 4.X M shares.
πŸ‘οΈ0
Nealio Nealio 2 years ago
CALA in play! Drug data and earnings report. Should move even higher on this news.
πŸ‘οΈ0
Nealio Nealio 2 years ago
Chart looks very good atm.
πŸ‘οΈ0
Nealio Nealio 2 years ago
Could be the start of a big run; or not. We shall see; with recent good news, I like the chances. Good luck to all!
πŸ‘οΈ0
ttottip ttottip 2 years ago
Yes.
πŸ‘οΈ0
ttottip ttottip 2 years ago
Good morning all! Hoping for a reversal today.
πŸ‘οΈ0
ttottip ttottip 2 years ago
I'm not hesitating to buy at these levels!
πŸ‘οΈ0
bandit007 bandit007 2 years ago
Took a few here. $CALA
πŸ‘οΈ0
kzivann kzivann 2 years ago
Moving after hours.

CALA
πŸ‘οΈ0
crudeoil24 crudeoil24 2 years ago
Calithera Biosciences shares are trading higher after Ladenburg Thalmann initiated coverage on the stock with a Buy rating and a $4 price target.

CALA
πŸ‘οΈ0
TheFinalCD TheFinalCD 2 years ago
big move 45-74


$CALA
πŸ‘οΈ0
glens0 glens0 3 years ago
$CALA .58 w/ $3 price upgrade out by Leerink
πŸ‘οΈ0
Eagle1 Eagle1 3 years ago
Thank you
πŸ‘οΈ0
crudeoil24 crudeoil24 3 years ago
Company discontinued its KEAPSAKE clinical trial.
πŸ‘οΈ0
Eagle1 Eagle1 3 years ago
Hi why the drop here?
πŸ‘οΈ0
0210 0210 3 years ago
Calithera Biosciences CALA Q3 EPS $(0.15) Beats $(0.23) Estimate, Sales $6.75M, and a 53.13 percent increase over losses of $(0.32) per share from the same period last year.

4:42 pm ET November 9, 2021 (Benzinga)
Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.23) by 34.78 percent. This is a 53.13 percent increase over losses of $(0.32) per share from the same period last year. The company reported $6.75 million in sales this quarter.
πŸ‘οΈ0
0210 0210 3 years ago
right-on-the-money...-54% to $0.86-0.87, from $1.90 on 21x dmav (of only 1,082,848 daily moving average volume).

SOURCE: https://ih.advfn.com/stock-market/NASDAQ/calithera-biosciences-CALA/historical

πŸ‘οΈ0
willlbone willlbone 3 years ago
Bid at 60% drop.
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
$CALA -40%

Calithera Biosciences, Inc. | Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial

https://ir.calithera.com/news-releases/news-release-details/calithera-biosciences-announces-decision-discontinue-keapsake
πŸ‘οΈ0
Elgordo84 Elgordo84 3 years ago
I’m expecting earnings to be on the up tomorrow
Let’s go $CALA
πŸ‘οΈ0
Elgordo84 Elgordo84 3 years ago
Looks like no one is paying attention
$CALA I guess is you and me!!!
Perfect for the run
While no one is watching.......
πŸ‘οΈ0
Elgordo84 Elgordo84 3 years ago
Ok hello $CALA
I LIKE WHAT I SEE HERE!!!!
Let’s take this for a ride...
$CALA LETS GO β€”β€”β€”β€”β€”>

πŸ‘οΈ0
trade-stock000 trade-stock000 3 years ago
Cala when is the data due date? Thx
πŸ‘οΈ0
oaps222 oaps222 3 years ago
Thanks for the info.
Geez~~, what a move. I wish I knew it last Thursday! LOL

In any event, congratulations, if you already got in ARTL!
πŸ‘οΈ0
trade-stock000 trade-stock000 3 years ago
A-R-T-L is the one to watch (: PT $8-10
Add on correction price, read few post over there abt data and cocrystal CBD molecules. Apart from that it's focused on Lipid therapy the next frontier in Oncology.
πŸ‘οΈ0
oaps222 oaps222 3 years ago
Very good point, but be careful. The market is crazy. I can see some (big?) corrections in the near future.
πŸ‘οΈ0
oaps222 oaps222 3 years ago
From the recent 13G Filings, Adage Capital has reported its 4,000,000 shares of CALA (5.67% ownership) on Jan 13, 2021.
πŸ‘οΈ0
trade-stock000 trade-stock000 3 years ago
Yeah but in Jan that was not much of an update, that´s why stock plummeted, company needs more time.

Jan option price rose becoz of that reason, now fade out. Will visit this ticker later, for now it´s waste of cash esp when whole market is running nut
πŸ‘οΈ0
oaps222 oaps222 3 years ago
Was it on Jan 15-17, not Feb 15-17?
http://www.calithera.com/wp-content/uploads/2021/01/Arginase-1158-203-Poster.pdf
πŸ‘οΈ0
trade-stock000 trade-stock000 3 years ago
IV surges in the event of future price move. $5 call for Feb 19 it seems someone very bullish abt this stock and bot calls. Article u cited it's from Jan-13th, today its 13th Feb (:, unless next week something comes out which is highly unlikely.
πŸ‘οΈ0
oaps222 oaps222 3 years ago
I was doing a DD on CALA and found the following. I don't quite understand it. Can you share your thoughts on this?
"Implied Volatility Surging for Calithera Biosciences (CALA) Stock Options"

https://finance.yahoo.com/news/implied-volatility-surging-calithera-biosciences-134001483.html
πŸ‘οΈ0
trade-stock000 trade-stock000 4 years ago
2.42 or lower test first before go up i hope
πŸ‘οΈ0
trade-stock000 trade-stock000 4 years ago
CALA on Feb 15-17 presenting Biliary-Tract Cancer-Data-could do-vroomvroom
πŸ‘οΈ0
jondoeuk jondoeuk 4 years ago
ASH abstract https://ash.confex.com/ash/2020/webprogram/Paper137266.html
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $CALA Video Chart 12-23-2019 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
cashbyers cashbyers 5 years ago
9.5M block trade today @ $4.45.. 17% stake or $42M investment...
πŸ‘οΈ0
ClayTrader ClayTrader 5 years ago
* * $CALA Video Chart 11-19-19 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
jonny_red jonny_red 5 years ago
4 Penny Stocks To Watch In November After Latest Milestones

$GTBP $CALA $AVDL $BLCM

https://www.transparenttraders.me/2019/11/4-penny-stocks-to-watch-in-november.html
πŸ‘οΈ0
cashbyers cashbyers 5 years ago
Long CALA @ $2.60
πŸ‘οΈ0
buypumps buypumps 5 years ago
Conference call Monday also. Could push to 3.90 area.
πŸ‘οΈ0
Zmill Zmill 5 years ago
TA of CALA https://msmoneymoves.com/2019/07/12/calithera-initiates-potential-buying-opportunity/
πŸ‘οΈ0
CashBowski CashBowski 5 years ago
CALA going to close the gap today.
πŸ‘οΈ0
Zmill Zmill 5 years ago
Research mentioning CALA https://wordpress.com/block-editor/post/msmoneymoves.com/11262
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock